D
Unicycive Therapeutics, Inc. UNCY
$4.23 -$0.02-0.47% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -31.50M -15.20M -36.73M -23.00M -23.24M
Total Depreciation and Amortization 530.00K 279.00K 428.00K 376.00K 332.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 4.40M -11.96M 8.15M -2.83M -2.15M
Change in Net Operating Assets -6.56M -4.14M -427.00K -1.01M 3.42M
Cash from Operations -33.12M -31.02M -28.58M -26.47M -21.64M
Capital Expenditure -68.00K -82.00K -72.00K -50.00K -26.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -68.00K -82.00K -72.00K -50.00K -26.00K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 14.80M 3.47M 683.00K -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock 0.00 0.00 50.00M 50.00M 50.00M
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid 0.00 -1.10M -1.10M -1.10M -1.10M
Other Financing Activities -1.07M -435.00K -4.50M -4.39M -4.28M
Cash from Financing 13.74M 1.94M 45.09M 44.52M 44.62M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -19.45M -29.16M 16.44M 18.00M 22.96M